Most Popular
Newsletter
Announcing the Cyagen YouTube Channel
Dec 17, 2020
Have you ever searched on YouTube for a biology concept that you didn’t fully understand, only to come across basic whiteboard tutorials or grainy homemade videos with people who can’t clearly explain the concepts? Given Cyagen’s position as a leading provider of custom genetically modified mouse and rat models worldwide, we felt drawn to answer the call for quality explainer videos related to the field of gene engineering. Read More >
Newsletter
Weekly Gene
[Gene of the Week] Alzheimer's Disease and Genes - TREM2
Dec 14, 2020
Specific mutations in TREM2 (Triggering Receptor Expressed on Myeloid Cells 2) have been confirmed to increase the risk of developing late-onset AD. Here, we review the current data detailing the function of TREM2 and its role in Alzheimer's disease (AD). Read More >
Newsletter
Large Fragment Knock-In Mouse Models Using Recombinase-Mediated Cassette Exchange
Dec 10, 2020
Since the beginnings of gene editing research, the ability to accurately modify large genomic regions has remained a primary driver of innovation in the field. Although gene editing technologies have been continuously refined, the size of the modifiable region is still constrained depending on the methods used. Read More >
Newsletter
New Cyagen Custom Mouse Model Publication Alert – December 2020
Dec 01, 2020
Herein, we have selected several high-impact factor (IF) publications from May through October 2020, which use custom genetically modified mouse models developed by Cyagen. These citations cover a broad range of research fields, including immunology, inflammation, cardiology, oncology, metabolomics, and epigenetics. Read More >
Research Trend
Newsletter
White Paper
Applications of the Mouse Model in Translational Medical Research
Nov 16, 2020
The mouse model has become an irreplaceable model organism for biomedical research, which includes studying gene function and genetic factors of pathogenesis, establishing humanized disease models, and evaluating the safety and effectiveness of drugs under development. Read More >
Weekly Gene
Research Trend
[Gene of the Week] Alzheimer's Disease and Genes - PSEN1 (Presenilin 1)
Nov 12, 2020
Alzheimer's disease (AD) is the most common age-related neurodegenerative disorder, which affects 20 to 30 million individuals worldwide. Currently, no effective therapies to treat or cure this disease have been developed. In this review, we discuss the current research and understanding of the PSEN1 gene and its mutation which causes familial Alzheimer's disease (FAD). Read More >
Newsletter
Research Trend
Genes of Fear – Halloween Special
Oct 29, 2020
Happy Halloween from Cyagen! To celebrate and educate, our team has put together brief synopses of several genes related to fear: STMN1, P4H-TM, ANXA1, FPR1, DAGLA, and TAAR1. Read on to learn about each gene’s functions, research progress, and opportunities for discovery. Read More >
Newsletter
THE TACONIC-CYAGEN ACADEMIC MODEL GENERATION ALLIANCE EXPERIENCE
Oct 29, 2020
Taconic Biosciences and Cyagen Biosciences have formed a strategic non-profit alliance. As partners, Taconic and Cyagen leverage the power of our complementary approaches to redefine the model generation customer experience by bringing the best and most competitive solutions to the market. Read More >
Newsletter
Consultations for Academic Researchers Interested in CAMA Grants
Oct 23, 2020
Academic researchers interested in utilizing mouse or rat models are invited to apply for the Taconic-Cyagen Custom Animal Model Awards (CAMA) competition – offering a range of grant awards valued over $77,350 that will help fund six (6) custom animal model (CAM) project proposals anticipated to most significantly impact their respective research fields. Read More >
Research Trend
Weekly Gene
[Gene of the Week] Alzheimer's Disease and Genes - APP (Amyloid Precursor Protein)
Oct 21, 2020
It is well known that genes play a major role in many human diseases - for this reason they are an important research topic in the field of life science and medicine. How can the public quickly grasp the recent research on disease-related genes, when the only resources out about them are long complex academic journals? Read More >